BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17201655)

  • 1. Filoviruses and the balance of innate, adaptive, and inflammatory responses.
    Mohamadzadeh M; Chen L; Olinger GG; Pratt WD; Schmaljohn AL
    Viral Immunol; 2006; 19(4):602-12. PubMed ID: 17201655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine research efforts for filoviruses.
    Hart MK
    Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Innate immunity evasion mechanisms of filoviruses].
    Martin B; Decroly É
    Med Sci (Paris); 2018; 34(8-9):671-677. PubMed ID: 30230452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential factors induced by filoviruses that lead to immune supression.
    Mohamadzadeh M
    Curr Mol Med; 2009 Mar; 9(2):174-85. PubMed ID: 19275625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cytokines and Chemokines in Filovirus Infection.
    Bixler SL; Goff AJ
    Viruses; 2015 Oct; 7(10):5489-507. PubMed ID: 26512687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of immunity to filovirus infection.
    Bradfute SB; Bavari S
    Viruses; 2011 Jul; 3(7):982-1000. PubMed ID: 21994766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.
    Martinez O; Leung LW; Basler CF
    Antiviral Res; 2012 Mar; 93(3):416-28. PubMed ID: 22333482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents.
    Warfield KL; Posten NA; Swenson DL; Olinger GG; Esposito D; Gillette WK; Hopkins RF; Costantino J; Panchal RG; Hartley JL; Aman MJ; Bavari S
    J Infect Dis; 2007 Nov; 196 Suppl 2():S421-9. PubMed ID: 17940979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against filovirus infection: virus-like particle vaccines.
    Yang C; Ye L; Compans RW
    Expert Rev Vaccines; 2008 Apr; 7(3):333-44. PubMed ID: 18393603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structural basis for filovirus neutralization by monoclonal antibodies.
    King LB; West BR; Schendel SL; Saphire EO
    Curr Opin Immunol; 2018 Aug; 53():196-202. PubMed ID: 29940415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a putative filovirus vaccine: virus-like particles.
    Martins KA; Warren TK; Bavari S
    Virol Sin; 2013 Apr; 28(2):65-70. PubMed ID: 23385315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filoviruses: One of These Things is (not) Like the Other.
    Anthony SM; Bradfute SB
    Viruses; 2015 Sep; 7(10):5172-90. PubMed ID: 26426036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filoviruses: Interactions with the host cell.
    Dolnik O; Kolesnikova L; Becker S
    Cell Mol Life Sci; 2008 Mar; 65(5):756-76. PubMed ID: 18158582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola and Marburg virus-like particles activate human myeloid dendritic cells.
    Bosio CM; Moore BD; Warfield KL; Ruthel G; Mohamadzadeh M; Aman MJ; Bavari S
    Virology; 2004 Sep; 326(2):280-7. PubMed ID: 15302213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa.
    Ogawa H; Miyamoto H; Nakayama E; Yoshida R; Nakamura I; Sawa H; Ishii A; Thomas Y; Nakagawa E; Matsuno K; Kajihara M; Maruyama J; Nao N; Muramatsu M; Kuroda M; Simulundu E; Changula K; Hang'ombe B; Namangala B; Nambota A; Katampi J; Igarashi M; Ito K; Feldmann H; Sugimoto C; Moonga L; Mweene A; Takada A
    J Infect Dis; 2015 Oct; 212 Suppl 2():S101-8. PubMed ID: 25786916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in virus-like particle vaccines for filoviruses.
    Warfield KL; Aman MJ
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1053-9. PubMed ID: 21987741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential vaccines and post-exposure treatments for filovirus infections.
    Friedrich BM; Trefry JC; Biggins JE; Hensley LE; Honko AN; Smith DR; Olinger GG
    Viruses; 2012 Sep; 4(9):1619-50. PubMed ID: 23170176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of reverse genetics systems in determining filovirus pathogenicity.
    Theriault S; Groseth A; Artsob H; Feldmann H
    Arch Virol Suppl; 2005; (19):157-77. PubMed ID: 16355872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Filovirus emergence and vaccine development: a perspective for health care practitioners in travel medicine.
    Sarwar UN; Sitar S; Ledgerwood JE
    Travel Med Infect Dis; 2011 May; 9(3):126-34. PubMed ID: 21208830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblastic reticular cells and their role in viral hemorrhagic fevers.
    Steele KE; Anderson AO; Mohamadzadeh M
    Expert Rev Anti Infect Ther; 2009 May; 7(4):423-35. PubMed ID: 19400762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.